GKB Ophthalmics Ltd

₹ 62.1 -2.60%

01 Jun - close price

About

Incorporated in 1981, GKB Ophthalmics Ltd is engaged in the manufacture and sale of ophthalmic lenses made up of Glass and
Plastic.^[1]

Key Points

Business Overview:^[1]^[2]
GKBOL is in the business of manufacturing semi-finished ophthalmic glass and plastic
lenses, viz., single-vision glass, single-vision plastic, bifocal plastic and photochromic
plastic lenses.

Website BSE

Market Cap ₹ 31.3 Cr.
Current Price ₹ 62.1
High / Low ₹ 91.7 / 45.2
Stock P/E 16.4
Book Value ₹ 105
Dividend Yield 0.00 %
ROCE 11.0 %
ROE 3.63 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Stock is trading at 0.59 times its book value
Company is expected to give good quarter

Cons

Company has a low return on equity of -4.73% over last 3 years.
Contingent liabilities of Rs.17.9 Cr.
Company's cost of borrowing seems high
Promoter holding has decreased over last 3 years: -7.96%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
	19.96	22.26	20.40	24.04	21.56	26.02	26.14	25.80	31.02	32.31	30.17	56.79	29.79
	20.35	20.91	20.69	24.66	21.56	24.98	26.20	26.74	33.88	31.51	27.15	55.13	26.71
Operating Profit	-0.39	1.35	-0.29	-0.62	0.00	1.04	-0.06	-0.94	-2.86	0.80	3.02	1.66	3.08
OPM %	-1.95%	6.06%	-1.42%	-2.58%	0.00%	4.00%	-0.23%	-3.64%	-9.22%	2.48%	10.01%	2.92%	10.34%
	0.23	0.35	0.31	0.35	0.60	0.28	0.28	0.48	0.35	0.21	0.37	0.57	-0.68
Interest	0.43	0.43	0.46	0.44	0.57	0.55	0.55	0.63	0.63	0.77	0.66	0.73	0.52
Depreciation	1.63	0.72	0.73	0.73	0.72	0.76	0.77	0.77	0.80	0.80	0.82	0.82	0.80
Profit before tax	-2.22	0.55	-1.17	-1.44	-0.69	0.01	-1.10	-1.86	-3.94	-0.56	1.91	0.68	1.08
Tax %	-4.95%	0.00%	0.00%	0.00%	30.43%	600.00%	5.45%	2.69%	4.82%	14.29%	3.66%	-4.41%	-3.70%
	-2.08	0.54	-1.19	-1.44	-0.89	0.11	-1.15	-1.91	-4.13	-0.64	1.84	0.70	1.12
EPS in Rs	-3.81	1.03	-2.32	-2.48	-1.81	-0.50	-2.42	-4.03	-7.04	-2.02	3.17	0.87	0.38
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	35	44	76	78	57	59	57	71	75	88	109	149
	34	44	75	77	56	56	55	66	72	88	112	140
Operating Profit	1	-1	2	1	1	2	2	5	4	1	-3	9
OPM %	2%	-2%	2%	2%	2%	4%	4%	7%	5%	1%	-3%	6%
	1	12	4	0	2	1	2	1	1	2	2	0
Interest	2	2	1	1	1	1	2	1	2	2	2	3
Depreciation	2	1	1	2	4	4	3	3	3	3	3	3
Profit before tax	-2	8	3	-1	-2	-2	-1	2	0	-3	-7	3
Tax %	-37%	50%	12%	-15%	-30%	0%	-19%	0%	14%	8%	5%	2%
	0	4	3	-1	-1	-2	-1	2	0	-3	-7	3
EPS in Rs	0.00	9.51	6.24	-2.34	-2.37	-3.65	-1.81	2.52	-0.34	-5.57	-13.97	2.42
Dividend Payout %		0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Compounded Sales Growth
10 Years:	13%
5 Years:	21%
3 Years:	25%
TTM:	37%

Compounded Profit Growth
10 Years:	11%
5 Years:	80%
3 Years:	145%
TTM:	127%

Stock Price CAGR
10 Years:	-1%
5 Years:	-3%
3 Years:	-15%
1 Year:	-19%

Return on Equity
10 Years:	-2%
5 Years:	-2%
3 Years:	-5%
Last Year:	4%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	4	4	4	4	5	5	5	5	5	5	5	5
Reserves	36	41	43	41	50	54	58	58	58	55	47	48
	9	7	7	10	14	15	12	12	11	11	14	12
	26	17	28	28	25	28	32	35	38	43	59	68
Total Liabilities	75	69	82	83	94	102	107	110	112	114	125	132
	12	13	18	18	26	26	24	23	19	18	17	15
CWIP	1	1	1	0	0	0	1	3	4	4	4	4
Investments	16	10	3	0	1	1	2	2	2	2	2	2
	46	46	60	64	68	75	80	82	87	91	102	111
Total Assets	75	69	82	83	94	102	107	110	112	114	125	132

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	7	-11	-3	-3	4	3	7	5	-3	4	-3
	-0	15	4	1	-10	-4	-17	-4	1	-2	3
	-6	-3	-1	1	13	4	3	-2	-2	-2	1
Net Cash Flow	1	0	-1	0	7	4	-7	-0	-4	1	-0
Free Cash Flow	7	-13	-9	-5	-6	-0	1	0	-2	2	-6
CFO/OP	1,117%	639%	-112%	-190%	346%	154%	300%	105%	-71%	865%	118%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	191	143	118	129	150	155	125	100	134	117	85	110
Inventory Days	424	285	225	223	289	301	349	307	298	245	250	189
Days Payable	343	156	169	168	217	234	234	208	183	202	195	195
Cash Conversion Cycle	271	272	174	184	222	223	239	199	249	160	141	104
Working Capital Days	97	156	111	115	110	110	117	105	135	97	78	78
ROCE %	-0%	-1%	3%	0%	-2%	-1%	3%	4%	2%	-1%	-6%	11%

Insights

In beta

Mar 2015

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Consolidated Revenue - Outside India
%

xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx
xxx	xxx	xxx	xxx	xxx	xxx	xxx	xxx	xxx	xxx	xxx
xx,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx		xx,xxx
xx,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx		xx,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx
		xxx	xxx	xxx	xxx	xxx	xxx	xxx	xxx	xxx
		xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx
									x,xxx,xxx	x,xxx,xxx

Please log in to see hidden values.

Total Permanent Employees
Number ・Standalone data

Average Daily Production
Pieces per day ・Standalone data

Installed capacity
Lenses per day ・Standalone data

Gross Current Asset (GCA) Days
Days ・Standalone data

Revenue from operations (Consolidated)
Rs. Crore

Production Volume (Annual)
Pieces of Lenses ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
	59.18%	50.86%	50.88%	50.93%	50.95%	50.95%	50.98%	50.99%	51.06%	51.06%	51.13%	51.13%
	1.79%	1.79%	1.79%	1.79%	1.79%	1.79%	1.79%	1.79%	1.79%	1.79%	1.79%	1.79%
	39.02%	47.36%	47.34%	47.28%	47.26%	47.28%	47.23%	47.23%	47.16%	47.17%	47.09%	47.09%
No. of Shareholders	2,030	2,115	2,233	2,370	2,690	2,510	2,539	2,538	2,550	2,601	2,661	2,634

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	71.17%	54.08%	48.41%	48.97%	59.44%	59.72%	59.09%	50.93%	50.99%	51.13%
	0.00%	0.00%	2.15%	1.98%	1.98%	1.98%	1.79%	1.79%	1.79%	1.79%
	0.47%	0.47%	0.43%	0.39%	0.39%	0.00%	0.00%	0.00%	0.00%	0.00%
	28.36%	45.45%	49.02%	48.65%	38.19%	38.29%	39.13%	47.28%	47.23%	47.09%
No. of Shareholders	1,113	1,135	1,226	1,204	1,185	1,432	1,933	2,370	2,538	2,634

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

GKB Ophthalmics Ltd

GKB Ophthalmics Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Insights

Shareholding Pattern

Documents

Announcements

Annual reports

Credit ratings